{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:13:12Z","timestamp":1789985592495,"version":"4.0.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-025-03872-1","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T16:06:08Z","timestamp":1763136368000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Extended-spectrum \u03b2-lactamase and carbapenemase-producing bacteria urinary tract infections in adult HIV-positive outpatients at Embu County Referral Hospital, Kenya"],"prefix":"10.1186","volume":"25","author":[{"given":"Norah Kagwiria","family":"Kiongo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Maingi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin Wangira","family":"Nyongesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abednego Moki","family":"Musyoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"key":"3872_CR1","unstructured":"HIV data and statistics. Available from: https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/strategic-information\/hiv-data-and-statistics. Cited 2024 Jul 4.\u00a0"},{"key":"3872_CR2","unstructured":"National Syndemic Disease Control Council. Available from: https:\/\/nsdcc.go.ke\/. National Syndemic Disease Control Council \u2013 NSDCC.\u00a0Cited 2024 Jul 13."},{"issue":"1","key":"3872_CR3","doi-asserted-by":"publisher","first-page":"e0190564","DOI":"10.1371\/journal.pone.0190564","volume":"13","author":"A Skrzat-Klapaczy\u0144ska","year":"2018","unstructured":"Skrzat-Klapaczy\u0144ska A, Mat\u0142osz B, Bednarska A, Paciorek M, Firl\u0105g-Burkacka E, Horban A, et al. Factors associated with urinary tract infections among HIV-1 infected patients. PLoS ONE. 2018;13(1):e0190564.","journal-title":"PLoS ONE"},{"key":"3872_CR4","doi-asserted-by":"publisher","unstructured":"Davey P, Wilcox M, Irving W, Thwaites G. Infections in immunocompromised patients, including HIV\/AIDS. In: Davey P, Wilcox MH, Irving W, Thwaites G, editors. Antimicrobial Chemotherapy. Oxford University Press; 2015:0. Available from: https:\/\/doi.org\/10.1093\/med\/9780199689774.003.0031. Cited 2024 Jul 4.","DOI":"10.1093\/med\/9780199689774.003.0031"},{"key":"3872_CR5","doi-asserted-by":"crossref","unstructured":"Amaya-Tapia G, Ibarra-Nieto G, Rivas OC, S\u00e1nchez JLG, Amaya-Tapia G, Ibarra-Nieto G, et al. Urinary Tract Infection in HIV\/AIDS Patients. In: Urinary Tract Infections - New Insights. IntechOpen; 2023. Available from: https:\/\/www.intechopen.com\/chapters\/86166. Cited 2024 Jul 4.","DOI":"10.5772\/intechopen.110017"},{"issue":"1","key":"3872_CR6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1556\/EuJMI-D-14-00036","volume":"5","author":"OA Olowe","year":"2015","unstructured":"Olowe OA, Ojo-Johnson BB, Makanjuola OB, Olowe RA, Mabayoje VO. Detection of bacteriuria among human immunodeficiency virus seropositive individuals in Osogbo, south-western Nigeria. Eur J Microbiol Immunol (Bp). 2015;5(1):126\u201330.","journal-title":"Eur J Microbiol Immunol (Bp)"},{"key":"3872_CR7","first-page":"4042686","volume":"1","author":"T Chaula","year":"2017","unstructured":"Chaula T, Seni J, Ng\u2019walida N, Kajura A, Mirambo MM, DeVinney R, et al. Urinary Tract Infections among HIV-Positive Pregnant Women in Mwanza City, Tanzania, Are High and Predicted by Low CD4+ Count. Int J Microbiol. 2017;1:4042686.","journal-title":"Int J Microbiol."},{"issue":"5","key":"3872_CR8","doi-asserted-by":"publisher","first-page":"e0296480","DOI":"10.1371\/journal.pone.0296480","volume":"19","author":"M Tilahun","year":"2024","unstructured":"Tilahun M, Fiseha M, Alebachew M, Gedefie A, Ebrahim E, Tesfaye M, et al. Uro-pathogens: Multidrug resistance and associated factors of community-acquired UTI among HIV patients attending antiretroviral therapy in Dessie Comprehensive Specialized Hospital, Northeast Ethiopia. PLoS ONE. 2024;19(5):e0296480.","journal-title":"PLoS ONE"},{"issue":"11","key":"3872_CR9","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1007\/s00345-019-03071-4","volume":"38","author":"R \u00d6zt\u00fcrk","year":"2020","unstructured":"\u00d6zt\u00fcrk R, Murt A. Epidemiology of urological infections: a global burden. World J Urol. 2020;38(11):2669\u201379.","journal-title":"World J Urol"},{"key":"3872_CR10","unstructured":"Target product profiles for oral therapy of urinary tract infections. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240003873. Cited 2024 Jul 13."},{"key":"3872_CR11","doi-asserted-by":"publisher","unstructured":"Hantalo AH, Shano AK, Meja TI. Correlation of CD4+ count and viral load with urinary tract infection and antimicrobial resistance pattern of bacterial uropathogens among HIV patients in Wolaita Sodo, South Ethiopia. Front Microbiol. 2024;15. Available from: https:\/\/www.frontiersin.org\/journals\/microbiology\/articles\/. https:\/\/doi.org\/10.3389\/fmicb.2024.1363287\/full.Cited 2024 Jul 13.","DOI":"10.3389\/fmicb.2024.1363287\/full"},{"issue":"6","key":"3872_CR12","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.cmi.2021.03.026","volume":"27","author":"ID Olaru","year":"2021","unstructured":"Olaru ID, Tacconelli E, Yeung S, Ferrand RA, Stabler RA, Hopkins H, et al. The association between antimicrobial resistance and HIV infection: a systematic review and meta-analysis. Clin Microbiol Infect. 2021;27(6):846\u201353.","journal-title":"Clin Microbiol Infect"},{"key":"3872_CR13","unstructured":"GARDP. 2023. The threat of AMR for people living with HIV. Available from: https:\/\/gardp.org\/stories\/the-threat-of-amr-for-people-living-with-hiv-a-south-african-doctors-perspective\/. Cited 2024 Jul 4."},{"key":"3872_CR14","unstructured":"Sabih A, Leslie SW. Complicated Urinary Tract Infections. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK436013\/. Cited 2024 Jul 4."},{"issue":"12","key":"3872_CR15","doi-asserted-by":"publisher","first-page":"22290","DOI":"10.1038\/s41598-022-26842-3","volume":"24","author":"T Ita","year":"2022","unstructured":"Ita T, Luvsansharav UO, Smith RM, Mugoh R, Ayodo C, Oduor B, et al. Prevalence of colonization with multidrug-resistant bacteria in communities and hospitals in Kenya. Sci Rep. 2022;24(12):22290.","journal-title":"Sci Rep"},{"key":"3872_CR16","unstructured":"WHO bacterial priority pathogens list, 2024: Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240093461. Cited 2024 Jul 11."},{"issue":"1","key":"3872_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40560-020-0429-6","volume":"8","author":"T Sawa","year":"2020","unstructured":"Sawa T, Kooguchi K, Moriyama K. Molecular diversity of extended-spectrum \u03b2-lactamases and carbapenemases, and antimicrobial resistance. J Intensive Care. 2020;8(1):13.","journal-title":"J Intensive Care"},{"key":"3872_CR18","unstructured":"Global action plan on antimicrobial resistance. Available from: https:\/\/www.who.int\/publications-detail-redirect\/9789241509763. Cited 2023 Aug 12."},{"key":"3872_CR19","doi-asserted-by":"crossref","unstructured":"Nyirenda T. The Conversation. 2023. Antibiotic resistance causes more deaths than malaria and HIV\/Aids combined. What Africa is doing to fight this silent epidemic. Available from: http:\/\/theconversation.com\/antibiotic-resistance-causes-more-deaths-than-malaria-and-hiv-aids-combined-what-africa-is-ng-to-fight-this-silent-epidemic-217689. Cited 2024 Jul 8.\u00a0","DOI":"10.64628\/AAJ.5ffxvws5e"},{"key":"3872_CR20","unstructured":"O\u2019Neill J. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. Rev Antimicrob Resist. 2014 Available from: https:\/\/cir.nii.ac.jp\/crid\/1370857593729357568. Cited 2024 Jul 11."},{"issue":"10325","key":"3872_CR21","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJL Murray","year":"2022","unstructured":"Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Aguilar GR, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629\u201355.","journal-title":"Lancet"},{"key":"3872_CR22","unstructured":"Antimicrobial resistance in Africa | Institute for Health Metrics and Evaluation. Available from: https:\/\/www.healthdata.org\/news-events\/insights-blog\/global-health-insights\/antimicrobial-resistance-africa. Cited 2024 Jul 11."},{"key":"3872_CR23","unstructured":"Administrator. World Health Organization - Regional Office for the Eastern Mediterranean. Available from: http:\/\/www.emro.who.int\/health-topics\/drug-resistance\/global-action-plan.html. Cited 2024 Mar 22. Global Action Plan on Antimicrobial Resistance."},{"key":"3872_CR24","unstructured":"KHHSR. Available from: https:\/\/analytics.nsdcc.go.ke\/. Cited 2024 Aug 5."},{"key":"3872_CR25","unstructured":"HIV \u2013 Prevalence of HIV among adults aged 15 to 49 (%). Available from: https:\/\/www.who.int\/data\/gho\/data\/indicators\/indicator-details\/GHO\/prevalence-of-hiv-among-adults-aged-15-to-49-(-). Cited 2024 Aug 5."},{"issue":"1","key":"3872_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/bimj.201300048","volume":"56","author":"SH Jung","year":"2014","unstructured":"Jung SH. Stratified Fisher\u2019s exact test and its sample size calculation. Biom J. 2014;56(1):129\u201340.","journal-title":"Biom J"},{"issue":"1","key":"3872_CR27","doi-asserted-by":"publisher","first-page":"10790","DOI":"10.1038\/s41598-020-67840-7","volume":"10","author":"NN Tessema","year":"2020","unstructured":"Tessema NN, Ali MM, Zenebe MH. Bacterial associated urinary tract infection, risk factors, and drug susceptibility profile among adult people living with HIV at Haswassa University Comprehensive Specialized Hospital, Hawassa, Southern Esthiopia. Sci Rep. 2020;10(1):10790.","journal-title":"Sci Rep"},{"key":"3872_CR28","unstructured":"Indian Council of Medical Research. Standard Operating Procedures Bacteriology. Division of Publication and Information; 2019. Available from: https:\/\/main.icmr.nic.in\/sites\/default\/files\/guidelines\/Bacteriology_SOP_2nd_Ed_2019.pdf. Cited 2024 Jun 8."},{"key":"3872_CR29","unstructured":"Clinical & Laboratory Standards Institute. Available from: https:\/\/clsi.org\/standards\/products\/microbiology\/documents\/m100\/. Cited 2023 Aug 12. M100Ed33 | Performance Standards for Antimicrobial Susceptibility Testing, 33rd Edition."},{"issue":"9","key":"3872_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ijregi.2023.07.007","volume":"1","author":"CK Mutuma","year":"2023","unstructured":"Mutuma CK, Maingi J, Maina AK, Njeru J, Musyoki AM. Asymptomatic gastrointestinal carriage of multidrug-resistant carbapenemase-producing Enterobacteriaceae among children under five years in a Kenyan hospital. IJID Regions. 2023;1(9):25\u201331.","journal-title":"IJID Regions"},{"issue":"1","key":"3872_CR31","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12941-023-00641-8","volume":"22","author":"JM Mutua","year":"2023","unstructured":"Mutua JM, Njeru JM, Musyoki AM. Extended-spectrum \u03b2-lactamase- producing gram-negative bacterial infections in severely ill COVID-19 patients admitted in a national referral hospital, Kenya. Ann Clin Microbiol Antimicrob. 2023;22(1):91.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"9","key":"3872_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ijregi.2023.10.007","volume":"1","author":"F Kipsang","year":"2023","unstructured":"Kipsang F, Munyiva J, Menza N, Musyoki A. Carbapenem-resistant Acinetobacter baumannii infections: Antimicrobial resistance patterns and risk factors for acquisition in a Kenyan intensive care unit. IJID Regions. 2023;1(9):111\u20136.","journal-title":"IJID Regions"},{"key":"3872_CR33","doi-asserted-by":"publisher","first-page":"6780354","DOI":"10.1155\/2019\/6780354","volume":"2019","author":"D Marami","year":"2019","unstructured":"Marami D, Balakrishnan S, Seyoum B. Prevalence, Antimicrobial Susceptibility Pattern of Bacterial Isolates, and Associated Factors of Urinary Tract Infections among HIV-Positive Patients at Hiwot Fana Specialized University Hospital, Eastern Ethiopia. Can J Infect Dis Med Microbiol. 2019;2019:6780354.","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"1","key":"3872_CR34","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1186\/s12879-021-06865-3","volume":"21","author":"G Abongomera","year":"2021","unstructured":"Abongomera G, Koller M, Musaazi J, Lamorde M, Kaelin M, Tasimwa HB, et al. Spectrum of antibiotic resistance in UTI caused by Escherichia coli among HIV-infected patients in Uganda: a cross-sectional study. BMC Infect Dis. 2021;21(1):1179.","journal-title":"BMC Infect Dis"},{"issue":"14","key":"3872_CR35","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.2147\/IDR.S299776","volume":"22","author":"BN Ngowi","year":"2021","unstructured":"Ngowi BN, Sunguya B, Herman A, Chacha A, Maro E, Rugarabamu LF, et al. Prevalence of Multidrug Resistant UTI Among People Living with HIV in Northern Tanzania. Infect Drug Resist. 2021;22(14):1623\u201333.","journal-title":"Infect Drug Resist"},{"issue":"2","key":"3872_CR36","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4103\/2321-9157.126630","volume":"1","author":"A Banu","year":"2013","unstructured":"Banu A, Jyothi R. Asymptomatic bacteriuria in HIV positive individuals in a tertiary care hospital. Journal of HIV and Human Reproduction. 2013;1(2):54.","journal-title":"Journal of HIV and Human Reproduction"},{"key":"3872_CR37","doi-asserted-by":"crossref","unstructured":"M.l KY, Samreen S. Asymptomatic urinary tract infection with multidrug resistant pathogens in retro positive patients on ART. Int J Med Res Rev. 2017;5(6):610\u20135.","DOI":"10.17511\/ijmrr.2017.i06.10"},{"issue":"4","key":"3872_CR38","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/ajt.13075","volume":"15","author":"M Bodro","year":"2015","unstructured":"Bodro M, Sanclemente G, Lipperheide I, Allali M, Marco F, Bosch J, et al. Impact of Antibiotic Resistance on the Development of Recurrent and Relapsing Symptomatic Urinary Tract Infection in Kidney Recipients. Am J Transplant. 2015;15(4):1021\u20137.","journal-title":"Am J Transplant"},{"key":"3872_CR39","unstructured":"Aggarwal N, Leslie SW, Lotfollahzadeh S. Recurrent Urinary Tract Infections. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557479\/. Cited 2024 Aug 8."},{"issue":"1","key":"3872_CR40","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1053\/j.ajkd.2023.08.009","volume":"83","author":"HA Lawati","year":"2024","unstructured":"Lawati HA, Blair BM, Larnard J. Urinary Tract Infections: Core Curriculum 2024. Am J Kidney Dis. 2024;83(1):90\u2013100.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"3872_CR41","first-page":"120","volume":"71","author":"JK Evans","year":"1995","unstructured":"Evans JK, McOwan A, Hillman RJ, Forster GE. Incidence of symptomatic urinary tract infections in HIV seropositive patients and the use of cotrimoxazole as prophylaxis against Pneumocystis carinii pneumonia. Genitourin Med. 1995;71(2):120\u20132.","journal-title":"Genitourin Med"},{"key":"3872_CR42","doi-asserted-by":"crossref","unstructured":"Carvalho NS de, Bertoldi BZ, Russo P da C. Urinary tract infection in HIV-positive women. Brazilian Journal of Sexually Transmitted Diseases. 2021;33. Available from: https:\/\/www.bjstd.org\/revista\/article\/view\/1172. Cited 2024 Jul 4.","DOI":"10.5327\/DST-2177-8264-20213329"},{"issue":"3\u20134","key":"3872_CR43","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0924-8579(99)00036-9","volume":"11","author":"S Sch\u00f6nwald","year":"1999","unstructured":"Sch\u00f6nwald S, Begovac J, Skerk V. Urinary tract infections in HIV disease. Int J Antimicrob Agents. 1999;11(3\u20134):309\u201311.","journal-title":"Int J Antimicrob Agents"},{"issue":"24","key":"3872_CR44","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12866-024-03297-2","volume":"27","author":"T Kahsay","year":"2024","unstructured":"Kahsay T, Gebrehiwot GT, Gebreyohannes G, Tilahun M, Gessese A, Kahsay A. Antimicrobial susceptibility patterns of urinary tract infections causing bacterial isolates and associated risk factors among HIV patients in Tigray, Northern Ethiopia. BMC Microbiol. 2024;27(24):148.","journal-title":"BMC Microbiol"},{"issue":"1","key":"3872_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190564","volume":"13","author":"A Skrzat-Klapaczy\u0144ska","year":"2018","unstructured":"Skrzat-Klapaczy\u0144ska A, Mat\u0142osz B, Bednarska A, Paciorek M, Firl\u0105g-Burkacka E, Horban A, et al. Factors associated with urinary tract infections among HIV-1 infected patients. PLoS ONE. 2018;13(1):e0190564.","journal-title":"PLoS ONE"},{"key":"3872_CR46","doi-asserted-by":"publisher","unstructured":"Cort\u00e9s-Cort\u00e9s G, Arenas-Hern\u00e1ndez MMP, Ballesteros-Monrreal MG, Rocha-Gracia R del C, Barrios-Villa E. Editorial: Epidemiology of antimicrobial resistance and virulence factors of emerging and re-emerging bacteria. Frontiers in Cellular and Infection Microbiology. 2024;14. Available from: https:\/\/www.frontiersin.org\/journals\/cellular-and-infection-microbiology\/articles\/. https:\/\/doi.org\/10.3389\/fcimb.2024.1387087Cited 2024 Aug 9.","DOI":"10.3389\/fcimb.2024.1387087"},{"issue":"3","key":"3872_CR47","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3390\/pathogens3030743","volume":"3","author":"C Vuotto","year":"2014","unstructured":"Vuotto C, Longo F, Balice MP, Donelli G, Varaldo PE. Antibiotic Resistance Related to Biofilm Formation in Klebsiella pneumoniae. Pathogens. 2014;3(3):743\u201358.","journal-title":"Pathogens"},{"issue":"1","key":"3872_CR48","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1186\/s12879-022-07885-3","volume":"22","author":"JM Mutua","year":"2022","unstructured":"Mutua JM, Njeru JM, Musyoki AM. Multidrug resistant bacterial infections in severely ill COVID-19 patients admitted in a national referral and teaching hospital, Kenya. BMC Infect Dis. 2022;22(1):877.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"3872_CR49","doi-asserted-by":"publisher","first-page":"5270","DOI":"10.3390\/ijerph19095270","volume":"19","author":"KB Said","year":"2022","unstructured":"Said KB, Alsolami A, Moussa S, Alfouzan F, Bashir AI, Rashidi M, et al. COVID-19 Clinical Profiles and Fatality Rates in Hospitalized Patients Reveal Case Aggravation and Selective Co-Infection by Limited Gram-Negative Bacteria. Int J Environ Res Public Health. 2022;19(9):5270.","journal-title":"Int J Environ Res Public Health"},{"key":"3872_CR50","unstructured":"AWaRe classification of antibiotics for evaluation and monitoring of use, 2023. Available from: https:\/\/www.who.int\/publications\/i\/item\/WHO-MHP-HPS-EML-2023.04. Cited 2024 Aug 9."},{"key":"3872_CR51","unstructured":"Antimicrobial resistance. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance. Cited 2023 Aug 11."},{"issue":"1","key":"3872_CR52","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13756-022-01202-y","volume":"12","author":"JW Kariuki","year":"2023","unstructured":"Kariuki JW, Jacobs J, Ngogang MP, Howland O. Antibiotic use by poultry farmers in Kiambu County, Kenya: exploring practices and drivers of potential overuse. Antimicrob Resist Infect Control. 2023;12(1):3.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"3872_CR53","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12941-023-00636-5","volume":"22","author":"JW Maina","year":"2023","unstructured":"Maina JW, Onyambu FG, Kibet PS, Musyoki AM. Multidrug-resistant Gram-negative bacterial infections and associated factors in a Kenyan intensive care unit: a cross-sectional study. Ann Clin Microbiol Antimicrob. 2023;22(1):85.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"Suppl 7","key":"3872_CR54","doi-asserted-by":"publisher","first-page":"S565","DOI":"10.1093\/cid\/ciz830","volume":"69","author":"Y Doi","year":"2019","unstructured":"Doi Y. Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections. Clin Infect Dis. 2019;69(Suppl 7):S565\u201375.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"3872_CR55","first-page":"334","volume":"14","author":"CJ Nwokolo","year":"2022","unstructured":"Nwokolo CJ, Ugwu MC, Ejikeugwu CP, Iroha IR, Esimone CO. Incidence and antibiotic susceptibility profile of uropathogenic Escherichia coli positive for extended spectrum \u03b2-lactamase among HIV\/AIDS patients in Awka metropolis. Nigeria Iran J Microbiol. 2022;14(3):334\u201340.","journal-title":"Nigeria Iran J Microbiol"},{"issue":"2","key":"3872_CR56","doi-asserted-by":"publisher","first-page":"dlab082","DOI":"10.1093\/jacamr\/dlab082","volume":"3","author":"ID Olaru","year":"2021","unstructured":"Olaru ID, Ferrand RA, Chisenga M, Yeung S, Macrae B, Chonzi P, et al. Prevalence of ESBL-producing Escherichia coli in adults with and without HIV presenting with urinary tract infections to primary care clinics in Zimbabwe. JAC Antimicrob Resist. 2021;3(2):dlab082.","journal-title":"JAC Antimicrob Resist."},{"issue":"3","key":"3872_CR57","first-page":"dlab092","volume":"3","author":"M Castanheira","year":"2021","unstructured":"Castanheira M, Simner PJ, Bradford PA. Extended-spectrum \u03b2-lactamases: an update on their characteristics, epidemiology and detection. JAC-Antimicro Resist. 2021;3(3):dlab092.","journal-title":"JAC-Antimicro Resist."},{"key":"3872_CR58","doi-asserted-by":"crossref","unstructured":"Magnitude of Multidrug-resistant Bacterial Uropathogens and Associated Factors in Urinary Tract Infection Suspected Adult HIV-Positive Patients in Southern Ethiopia. Open Microbiol J. 2022;16. Available from: https:\/\/www.sciencedirect.com\/org\/science\/article\/pii\/S1874285822000152. Cited 2024 Aug 12.","DOI":"10.2174\/18742858-v16-e2208180"},{"key":"3872_CR59","doi-asserted-by":"crossref","unstructured":"Simeneh E, Gezimu T, Woldemariam M, Alelign D. Magnitude of Multidrug-resistant Bacterial Uropathogens and Associated Factors in Urinary Tract Infection Suspected Adult HIV-Positive Patients in Southern Ethiopia. Available from: https:\/\/openmicrobiologyjournal.com\/VOLUME\/16\/ELOCATOR\/e187428582208180\/. Cited 2024 Aug 12.","DOI":"10.2174\/18742858-v16-e2208180"},{"issue":"2","key":"3872_CR60","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.juro.2010.03.139","volume":"184","author":"D Scholes","year":"2010","unstructured":"Scholes D, Hawn TR, Roberts PL, Li SS, Stapleton AE, Zhao LP, et al. Family History and Risk of Recurrent Cystitis and Pyelonephritis in Women. J Urol. 2010;184(2):564\u20139.","journal-title":"J Urol"},{"issue":"4","key":"3872_CR61","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1086\/315827","volume":"182","author":"D Scholes","year":"2000","unstructured":"Scholes D, Hooton TM, Roberts PL, Stapleton AE, Gupta K, Stamm WE. Risk Factors for Recurrent Urinary Tract Infection in Young Women. J Infect Dis. 2000;182(4):1177\u201382.","journal-title":"J Infect Dis"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-03872-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-03872-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-03872-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T01:03:59Z","timestamp":1763168639000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-025-03872-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3872"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-03872-1","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"16 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study obtained informed consent from each patient and carried out the research project following the Declaration of Helsinki, observing participants\u2019 well-being, confidentiality, and ensuring the clinicians in charge of the patients got results timely on all critical findings. The protocol ethical clearance was obtained from the Kenyatta University Ethical Review Committee (PKU\/2453\/11584), whereas the National Commission for Science and Innovation (Ref No. Ref No: 933594) and Embu County Referral Hospital management issued the research permit.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"743"}}